Abstract:Objective:To explore the efficacy and influencing factors of radiofrequency ablation (RFA) in the treatment of colorectal cancer liver metastases (CRLM).Methods:The clinical and imaging data of 281 patients (477 intrahepatic metastatic tumors) who received percutaneous RFA treatment in Sir Run Run Shaw Hospital, Zhejiang University School of Medicine from December 2009 to December 2020 were retrospectively analyzed. Factors that may affect the efficacy of RFA were recorded, including carcinoembryonic antigen (CEA), differentiation, extrahepatic metastasis, tumor location and size, complications and other information. Patients were followed up through hospital admissions, telephone, etc. The primary endpoints were overall survival (OS) and local tumor progression-free survival (LTPFS). Univariate and multivariate logistic regression models were used to identify predictors of residual tumor. Univariate and multivariate Cox proportional hazards regression were used to identify the influencing factors of LTPFS and OS. The median LTPFS and OS were estimated by the Kaplan-Meier curve and compared by the log-rank test.Results:After RFA, 68 (14.3%) tumor residues were observed. Multivariate logistic regression showed that the risk factors for residual tumor were size ≥20 mm, high-risk and perivascular location, and minimal ablative margin<5 mm. During the follow-up period, the main complication rate was 4.3% (12/281) and the fatality rate was 31.3% (88/281). At the same time, local tumor progression was found in 167 (35.0%) lesions post-RFA. The median time of LTPFS and OS estimated by the Kaplan Meier method were 35.0 (95%CI 26.53-43.48) and 44.0 (95%CI 29.70-58.30) months, respectively. The cumulative proportion of LTPFS and OS were 37.2% and 40.4% respectively in the 5th year. Multivariate Cox proportional hazard regression showed that CEA≥30 ng/ml, tumor size ≥20 mm, and minimal ablative margin<5 mm were risk factors for LTPFS; extrahepatic metastasis, tumor burden>30 mm, and lesion with minimal ablative margin<5 mm were independent risk factors for OS; re-intervention was an independent protective factor for OS.Conclusions:Adequate ablative margin and less tumor burden were beneficial to local tumor control and long-term survival of patients in the RFA treatment; the existence of extrahepatic metastasis was an important risk factor for OS, and re-interventional therapy was beneficial to extend OS.

Risk Factors for Hospitalization Duration Longer Than 24 Hours Following Percutaneous Radiofrequency Ablation of Liver Tumours

Thrombotic Thrombocytopenic Purpura after Radiofrequency Ablation of Hepatocellular Carcinoma: A Case Report.

Periprocedural Risk Factors for Incomplete Radiofrequency Ablation of Liver Metastases from Colorectal Cancer: a Single-Center Retrospective Analysis

Major Complications after Radiofrequency Ablation for Liver Tumors: Analysis of 255 Patients.

Risk factors for 302 hepatic malignancies cases with residual tumor after ultrasound-guided radiofrequency ablation treatment

[Prognosis and Risk Factors for Recurrence of Small Liver Cancer after a Single Session of Percutaneous Radiofrequency Ablation].

Risk Factors for Recurrence of Small Hepatocellular Carcinoma after Long-Term Follow-Up of Percutaneous Radiofrequency Ablation

Analysis of therapeutic effect and influencing factors of radiofrequency ablation for colorectal cancer liver metastases

Gastrointestinal tract perforation after radiofrequency ablation for hepatic tumor: Incidence and risk factors

Incidence and risk factors of liver abscess after radiofrequency ablation for liver cancer

Intraperitoneal Hemorrhage During and after Percutaneous Radiofrequency Ablation of Hepatic Tumors: Reasons and Management

Intrahepatic biliary injuries associated with radiofrequency ablation of hepatic malignancies.

Intrahepatic Distant Recurrence Following Complete Radiofrequency Ablation of Small Hepatocellular Carcinoma: Risk Factors and Early MRI Evaluation

Ten-year survival of hepatocellular carcinoma patients undergoing radiofrequency ablation as a first-line treatment

Long-term efficacy of radiofrequency ablation in 446 patients with hepatocellular carcinoma]

Radiofrequency Ablation of Hepatocellular Carcinoma: Long-Term Outcome and Prognostic Factors

Clinical short-term results of radiofrequency ablation in liver cancers.

Long-Term Outcome Of Percutaneous Radiofrequency Ablation In Recurrent Hepatocellular Carcinoma After Liver Transplantation

Radiofrequency ablation of hepatocellular carcinoma in difficult locations: Strategies and long-term outcomes.

Recurrence after percutaneous radiofrequency ablation of hepatocellular carcinoma: Analysis of the pattern and risk factors

Hepatic abscess with hepatobronchial fistula following percutaneous radiofrequency ablation for hepatocellular carcinoma: A case report